• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On RDHL

    RedHill Biopharma Ltd. (RDHL)

    -NasdaqCM
    12.15 0.49(3.88%) Dec 19, 3:59PM EST
    Add to Portfolio
    Prev Close:12.64
    Open:12.64
    Bid:N/A
    Ask:12.68 x 300
    1y Target Est:26.25
    Beta:0.044
    Next Earnings Date:N/A
    Day's Range:12.01 - 12.94
    52wk Range:6.89 - 21.00
    Volume:4,400
    Avg Vol (3m):8,220
    Market Cap:106.80M
    P/E (ttm):N/A
    EPS (ttm):-1.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RDHL

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.31
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RedHill Biopharma Ltd. is an Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback